NewsBenzingaZentalis Pharmaceuticals presenta i dati della sua analisi intermedia dello studio DENALI Parte 1b al Congresso ESMO 2026 Zentalis Pharmaceuticals presenta i dati della sua analisi intermedia dello studio DENALI Parte 1b al Congresso ESMO 2026 Benzinga 2026.10.23 14:17 (GMT+0) Open on Benzinga Other news Nvidia Shares Rise After Earnings Beat in First Report Since Jensen Huang's Exit NVIDIA Chairman Harvey Jones: Board Has No Intention of Restoring Jensen Huang as CEO Slower Retail Sales Drag on Market SEC reportedly investigating Nvidia amid Huang exit A $3 Billion Reason Why Disney Stock Is in Focus Today Google joins the tech outage trend by announcing it’s not having one